News und Analysen
1 Growth Stock Down 40% to Buy Right Now
The problem with Pool Corp. (NASDAQ: POOL) is really an issue of perspective. What's most important to potential investors: Near-term performance or long-term opportunity?
Those that think
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Exelixis (EXEL) Q1 2023 Earnings Call Transcript
Image source: The Motley Fool.
Exelixis (NASDAQ: EXEL)Q1 2023 Earnings CallMay 09, 2023, 5:00 p.m. ET
Operator
Source Fool.com
EQS-News: United Internet gets off to good start in 2023
EQS-News: United Internet gets off to good start in 2023
EQS-News: Telefónica Deutschland Holding AG: Robust start to the year confirming FY23 outlook with ongoing commercial momentum driving sustained operational & financial performance
EQS-News: Telefónica Deutschland Holding AG: Robust start to the year confirming FY23 outlook with ongoing commercial momentum driving sustained operational & financial performance
EQS-News: Just – Evotec Biologics launches tech partnership for biosimilars development and commercial manufacturing
EQS-Adhoc: Just – Evotec Biologics enters strategic biosimilars partnership with Sandoz
Actually, There's a Glimmer of Hope In Peloton's Fiscal Q3 Report
The market is clearly less than thrilled with Peloton Interactive's (NASDAQ: PTON) fiscal third-quarter results and fourth-quarter outlook if Thursday's 14% post-earnings plunge is any indication
Etsy's Sales Are on the Decline. Is the Stock Still a Buy?
Etsy (NASDAQ: ETSY) was a pandemic phenomenon, producing triple-digit growth for several consecutive quarters as shoppers found its exclusive, handmade masks and stayed on for other fun and unique
Here's How Moderna Plans to Win in the Post-Emergency COVID Vaccine Market
High demand for coronavirus vaccines earlier in the pandemic pushed Moderna's (NASDAQ: MRNA) earnings into the stratosphere. Spikevax brought in billions of dollars in revenue and profits for the
Peloton Had Another Shaky Quarter, but Don't Rush to Sell the Stock
Last month, I said Peloton Interactive (NASDAQ: PTON) would be among the stocks I'd be watching the closest in May because it was scheduled to report its earnings results. The numbers were released
The Next 5 Years Could Be Even Bigger for Roku Than the Last 5 Years
Roku (NASDAQ: ROKU) quintupled its user base in the five years from 2017 through 2022, but the next five years could be even better.
The proliferation of streaming services has fueled the
The Vanguard Group, Inc.: Horizon Therapeutics plc
I Just Added Airbnb to My Stock Watchlist -- Here's Why
Airbnb (NASDAQ: ABNB) has been on quite a ride since the COVID-19 pandemic kneecapped the travel industry in 2020. For a while, the online marketplace for short- and long-term homestays and
Power Integrations Unveils New SCALE-iFlex LT NTC IGBT/SiC Module Gate Drivers with Temperature Readout
PCIM 2023 – Power Integrations (NASDAQ: POWI), the leader in gate-driver technology for medium- and high-voltage inverter applications, today introduced the SCALE-iFlex™ LT NTC family of IGBT/SiC
Power Integrations’ New 3300 V IGBT Module Gate Driver Reports Telemetry Data for Observability, Predictive Maintenance and Lifetime Modeling
PCIM 2023 – Power Integrations (NASDAQ: POWI), the leader in gate-driver technology for medium- and high-voltage inverter applications, today announced a new, single-channel, plug-and-play gate
EQS-News: Schaeffler AG: Schaeffler Group starts 2023 with good quarter
PacWest Bancorp Is Cutting its Dividend -- Shares Are Rising
Shares of PacWest Bancorp (NASDAQ: PACW) traded more than 7% higher as of 11:12 a.m. ET today after the bank announced late Friday night that it would nearly eliminate its dividend. Shares had been
Should Investors Buy the Dip in Etsy Stock?
Fool.com contributor and finance professor Parkev Tatevosian reviews Etsy's (NASDAQ: ETSY) latest financial results and lets you know if the stock is a buy on the dip.
*Stock prices used were the
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Is Moderna a Value Stock to Buy Right Now?
Moderna (NASDAQ: MRNA) can be described in several ways. A messenger RNA (mRNA) pioneer. A leader in the COVID-19 vaccine market. A cash-rich biotech company.
One description of Moderna you